YSS — YSS

STATUS UPDATE 2026-05-12

Reclassified from cull-candidate to HOLD. Original wiki agent recommended sweep based on (a) "1 share can't move portfolio" and (b) Goal #3 position count reduction. Both reasons were wrong for this name:

• Entry was January 2026 — only 3.5 months ago. Mike's pattern is multi-year hold to thesis maturity (PL sub-$5 entered 2023, matured 2024-26; RKLB sub-$10 same trajectory). Three months is not a valid evaluation window.
• Govt contracts (SDA Tranche 1 Tracking Layer) are real catalysts. Thesis-driven small-cap with confirmed institutional customer + post-IPO underperformance is the textbook setup Mike has exploited successfully before — early entry below consensus, patience through volatility, structural thesis playing out.

Sweep was reactive framing. Long-horizon hold is the correct stance. Re-evaluate at the 12-18 month mark (~Q1 2027) when contract execution data has accumulated and one full earnings cycle has passed.

Atom-pack update (2026-05-19)

Source: 4-atom synthesis (FY2025 10-K filed 2026-03-20; All.Space 8-K 2026-04-29; Q1 2026 earnings PR 2026-05-14; Q1 2026 10-Q 2026-05-15). Canonical thesis state: data/company_thesis_states/YSS.json. Pre-existing wiki content below is preserved verbatim; this overlay surfaces what the atom data has added since the 2026-05-12 reclassification.

Three-acquisition consolidation pivot

The filing arc reveals York executing three M&A actions in approximately nine months -- a thesis evolution from "small-sat bus manufacturer" to vertically-integrated small-sat ecosystem consolidator. The acquisitions:

• ATLAS Space Operations (closed August 29, 2025, $85.8M total consideration: $1.5M cash + $78.6M equity in Holdings units + $5.75M prior investment): added 45+ ground antennas and ground-station-as-a-service (GSaaS) capability
• Orbion Space Technology (closed March 6, 2026, $74.9M: $11.2M cash + $60.2M common stock at $34.00/share, 2,812,141 shares issued): added electric propulsion
• All.Space Holdings (definitive agreement April 29, 2026, $355M aggregate: ~$155M cash + 5,882,352 YSS shares): satellite communications terminal technology. Subject to HSR, UK NSIA, and FCC approvals. Outside Date 120 days from signing (~August 27, 2026), extendable up to 90 additional days in 30-day increments. All.Space was UK-domiciled until February 4, 2026 redomestication to Delaware; UK NSIA review is an independent gating condition. Equity consideration carries a 6/9-month staged lock-up.

The wiki's existing one-line thesis ("Domestic small-sat bus manufacturer riding the SDA proliferated constellation thesis") remains directionally accurate but understates the current operating reality. The long-horizon hold framing from the 2026-05-12 reclassification is intact; the M&A pivot is a thesis evolution worth flagging for the Q1 2027 re-evaluation.

Financial scale (FY2025 + Q1 2026)

• FY2025 revenue $386.2M (+52% YoY from $253.5M), ~96.5% government ($372.8M) -- principally SDA PWSA Tranches 0/1/2
• FY2025 GAAP gross margin 19.5% (up from 12.8% FY2024); Adj EBITDA $(8.3)M (improved from $(43.0)M FY2024)
• Q1 2026 revenue $116.3M (+9% YoY from $106.3M) -- growth rate decelerated from the FY2025 +52% pace
• Q1 2026 GAAP gross margin 19% (down from 23% Q1 2025); Adj EBITDA $(3.6)M (vs. +$5.5M Q1 2025)
• Q1 2026 GAAP net loss $(114.8)M dominated by $84.7M IPO-related stock-based compensation acceleration (non-cash, one-time) and $5.9M transaction costs
• Backlog: $542.6M at YE 2025 (107 spacecraft) → $642.3M at March 31, 2026. Gross new contract awards in Q1 ~$216M, principally the $187M commercial M-CLASS contract (20+ satellite constellation, customer not publicly disclosed -- York's first disclosed multi-hundred-million-dollar commercial win)
• FY2026 revenue guidance reaffirmed at $545M-$595M on the May 14 release (midpoint $570M = +47.6% over FY2025; the Q1 $116.3M run-rate implies Q2-Q4 must average ~$151M per quarter for midpoint)

Capital structure and IPO proceeds

• IPO closed January 30, 2026: 18.5M shares at $34.00/share = $582.6M net proceeds
• Q1 2026 cash $655.7M (vs. $162.6M at YE 2025); total liquidity $806M (cash plus $150M undrawn revolver)
• Term loan $149.1M outstanding at March 31, 2026; maturity extended subsequent to quarter-end to November 14, 2029
• All.Space ~$155M cash component represents ~23.6% of Q1 2026 cash. Pro forma post-close cash ~$500M before operating outflows.

Credit-agreement covenant trajectory

The stepped minimum-revenue covenants in the credit facility imply a back-end-loaded growth schedule the lender syndicate is underwriting: - $245.6M TTM at March 31, 2026 (current TTM ~$396.2M = ~61% above floor) - $372.5M TTM at December 31, 2026 - $617.0M TTM at December 31, 2027 - $758.5M TTM at September 30, 2028

The implied compounded growth rate from FY2025 $386M to the September 2028 $758.5M floor is approximately 23% per year. Minimum liquidity covenant separately requires $105M unrestricted cash + revolver availability per quarter-end.

Material weakness in revenue recognition controls

The ASC 606 percentage-of-completion ('cost-to-cost') accounting method governs essentially all York revenue recognition. A material weakness in internal controls -- specifically in 'identifying the correct measure of progress' for over-time revenue recognition -- was disclosed in the FY2025 10-K and remains unremediated in the Q1 2026 10-Q (two consecutive filings). Three other previously-identified material weaknesses (tax provision controls, preferred unit classification, cost reclassification) were remediated as of the 10-K filing. The unremediated weakness operates through the same mechanism that produced $(11.1)M net 'unfavorable' EAC adjustments in FY2025 ($(22.9)M in FY2024) and the $5.5M contract loss reserve recorded in Q1 2026 (vs. zero in Q1 2025). The company qualifies as an Emerging Growth Company under JOBS Act Section 404(b), so external auditor attestation on internal controls is not yet required; management states remediation is in process without a disclosed completion timeline.

Customer concentration and governance

• SDA represented 'substantially all' of FY2025 revenue and ~99% of Q1 2026 revenue. Concentration is a named risk factor.
• AE Industrial Partners holds ~24.2% of shares (30.2M shares) as of February 28, 2026; YSS qualifies as a 'controlled company' under NYSE rules. BlackRock 14.3%; CEO Dirk Wallinger 8.9%.
• Three risk-factor additions in scope: tariff/global trade environment, $151B SHIELD IDIQ ceiling (Golden Dome procurement pathway with risk if SDA is not centrally involved in contracting), and goodwill at $737.4M post-Orbion (56.2% of total assets pre-All.Space close).

One-line thesis

Domestic small-sat bus manufacturer riding the SDA proliferated constellation thesis — the manufacturing throughput layer of the orbital infrastructure stack — with first-mover government contracts validating early traction.

Position

• Probe (long-horizon) position entered January 2026 at the IPO entry point. STCG-locked through ~January 2027. Hold-only window unless thesis breaks.
• Reclassified from cull-candidate to long-horizon HOLD on 2026-05-12; re-evaluation cadence is the 12-18 month mark (~Q1 2027) when contract execution data has accumulated.

Thesis (detailed)

York Space Systems is a relatively new public domestic satellite bus manufacturer (Jan 2026 IPO entry per Mike's records). The S-CLASS bus platform targets the proliferated LEO constellation market — the Space Development Agency (SDA) Tranche 1 and Tranche 2 Tracking + Transport Layer programs require hundreds of satellites. York's differentiation: production speed and price at standardized scale, vs the slower bespoke approach of traditional defense primes (Lockheed, Northrop, L3Harris).

The orbital infrastructure macro thesis applies cleanly: if the next decade of national security space runs through proliferated LEO (hundreds of small satellites for tracking missiles, communications resilience, intelligence collection), then bus manufacturing throughput becomes a critical layer. York's positioning is upstream of PL/BKSY (data products) and parallel to but distinct from RKLB (vertically integrated launch + manufacturing). It is NOT a customer of PL/BKSY/LUNR but a complement — it makes the platforms others build payloads onto.

The macro tailwinds are real and government-funded: SDA awards already issued to York for Tranche 1; CHIPS Act and IRA semiconductor reshoring tailwinds touch space supply chain; defense budget steadily increasing on space programs. The bear case is execution risk on a young public company with limited cash reserves, plus competition from RKLB (which builds its own buses), Northrop, Raytheon, Sierra Space.

Mike's edge thesis: early position in a verified-contract-winner that the market hasn't priced because (a) post-IPO names are systematically underpriced for the first 6-18 months on lack of coverage, and (b) defense IT/space names have specific catalyst dependencies (program of record additions) that don't show up in earnings until 2-4 quarters after award. The pattern matches PL's 2023-2024 trajectory.

Recent catalysts (60-day rolling)

• 2026-01-29: Mike's entry (per Mike's records). IPO was earlier — verify exact IPO date
• 2026-Q1: Earnings disclosure not yet verified (couldn't confirm if quarterly cadence established post-IPO; check 10-Q filing status)
• Contract awards from SDA Tranche 2 expected through 2026-2027 — material catalysts when announced

Risks / What would break the thesis

• SDA program budget cut — primary institutional customer; congressional appropriations risk
• Contract loss on rebid — same risk that hit SAIC; if York loses next major Tranche to Northrop or another competitor, thesis weakens
• Cash burn / dilution — small-cap post-IPO names often raise capital in 12-24 months; check cash position and burn rate in 10-Q
• Manufacturing execution — if York misses delivery milestones on Tranche 1 commitments, the production-speed differentiation disappears
• RKLB internal manufacturing — Rocket Lab makes its own buses; if RKLB expands bus sales to third parties, that compresses York's addressable market

Triggers

HOLD (current state): Position is in the 3-18 month window where post-IPO names develop. Hard rule applies: thesis-driven plays mature over years, not months.

Re-evaluation triggers (which would warrant a hold/add/sweep decision): - Major SDA contract loss (>$100M program) — would weaken thesis materially - Cash burn issue disclosed in 10-Q indicating dilution within 6 months - Management departure (CEO/CFO/CTO) - Acquisition rumor at premium to current — opportunity to exit at strength - LTCG eligibility (~January 2027) — switch to LTCG-loss-harvest mathematics if still underwater

Reinforce trigger (graduation to T2): - Confirmed SDA Tranche 2 contract above $50M with named award - Two consecutive quarters of revenue growth >20% with margin expansion - Coverage initiation by named sell-side firm (validation signal)

External authoritative sources

• York Space Systems Company Website
• YSS SEC EDGAR filings
• SDA Tranche programs (SpaceNews tag)
• YSS analyst coverage (MarketBeat)

Open questions / hypotheses

1. What is YSS's IPO date and listing mechanism? Still not verified. Important for understanding pre-Mike-entry price discovery period.
2. Has YSS received SDA Tranche 2 awards as of May 2026? If yes, that materially strengthens the hold thesis.
3. What is YSS's cash position and quarterly burn rate? Pre-revenue or near-revenue small-caps live or die on this. Pre-2027 dilution would be a thesis stress test.
4. Does RKLB sell buses to third parties or only use internally? Bear case depends on this — if RKLB stays internal-only, York's addressable market is preserved.

Decision log

• 2026-01: Probe-tranche position entered at the IPO entry point.
• 2026-05-12 (morning): Wiki agent flagged as sweep candidate based on small position size + position count goal. Recommendation lacked depth (couldn't verify IPO date, earnings status, contract status).
• 2026-05-12 (evening): Mike corrected the call. Reclassified from cull-candidate to HOLD (long-horizon). Pattern recognition: Mike's thesis plays mature over years, not months; 3.5 months post-entry is not a valid evaluation window. Removed from sweep list. Re-evaluation at Q1 2027 or earlier on material catalyst.